Corcept Therapeutics Incorporated CORT
71.63 USD 0.00 (+0.00%)
At closeNov 6, 2026, 8:58 AM EST
72.22 +0.59 +0.82%
Pre-market · Nov 6, 8:58 AM ET
71.52 Day range 78.98
28.66 52-week range 126.38
- YTD
- +105.83%
- 1 year
- -6.55%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 761.41M | 675.04M | 482.38M | 401.86M | 365.98M | |
| 748.43M | 664.16M | 475.89M | 396.47M | 360.70M | |
| 44.80M | 136.95M | 107.28M | 112.63M | 124.48M | |
| 98.17M | 139.73M | 105.50M | 101.29M | 112.51M | |
| 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 120.50M | 127.67M | 135.55M | 66.33M | 77.62M | |
| 836.65M | 840.55M | 621.52M | 583.43M | 423.76M | |
| 188.85M | 160.96M | 114.81M | 81.59M | 47.95M | |
| 6.11M | 6.94M | 151.00K | 1.14M | 526.00K | |
| 647.80M | 679.59M | 506.70M | 501.84M | 375.81M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 142.00M | 198.29M | 126.68M | 120.32M | 167.89M | |
| 69.76M | -177.60M | 90.91M | -114.33M | 136.13M | |
| -220.37M | -28.35M | -148.72M | -17.28M | -302.59M | |
| -211.00K | -2.17M | -139.00K | -413.00K | -469.00K | |
| -7.17M | -7.89M | 69.22M | -11.29M | 1.43M |